Capwell Communications Information

Most life sciences companies have to raise large sums and earn trust over many years before they ever reach the market. The ones that make it are rarely the quietest. They are the companies investors, strategic partners, and clinicians already know and already understand. Capwell is the strategic PR partner that keeps emerging life sciences brands on the radar through that long climb. We do the positioning work up front, so the market finally understands why your company matters and what your advancement means for the standard of care. Then we keep a steady drumbeat of news, earned media, and executive visibility that makes you impossible to overlook. Over the past 16 years, Capwell has worked with leading medtech and biotech brands and health organizations, including Dexcom, Prolacta Bioscience, Ivantis, Galileo, Edwards Lifesciences, Evofem Biosciences, Ortho Clinical Diagnostics, National Stroke Association, Abbott Medical, WaveTec Vision, and the Schaeffer Center for Health Policy & Economics (to name a few). We move brands from early funding through FDA milestones and commercial growth to acquisition and exit. “Firms such as Capwell are doing work that is good enough to compete with the giant, multi-national agencies,” praised Inside PR. Capwell has also been named Best Boutique Agency by Bulldog Reporter seven years in a row. Our mission is to elevate the standard of care worldwide. We live this mission by building the reputation, credibility, and market momentum that life sciences startups need to reach exit, so their innovations can scale to millions more patients. Book a strategy call: capwellcomm.com